Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) – protocol for prospective cohort study

Peer Review reports

Original Submission
10 Jan 2020	Submitted	Original manuscript
20 May 2020	Author responded	Author comments - Delia Bogdanet
Resubmission - Version 2
20 May 2020	Submitted	Manuscript version 2
6 Jun 2020	Author responded	Author comments - Delia Bogdanet
Resubmission - Version 3
6 Jun 2020	Submitted	Manuscript version 3
13 Jun 2020	Author responded	Author comments - Delia Bogdanet
Resubmission - Version 4
13 Jun 2020	Submitted	Manuscript version 4
Publishing
3 Jul 2020	Editorially accepted
18 Jul 2020	Article published	10.1186/s12884-020-03090-9

Back to article page